Back
Halozyme Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
HALO
Halozyme Therapeutics
Last Price:
45.73
Seasonality Move:
17.34%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Halozyme Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.51 | Sell |
| 20-day SMA: | 53.43 | Sell |
| 50-day SMA: | 55.29 | Sell |
| 200-day SMA: | 49.09 | Sell |
| 8-day EMA: | 49.51 | Sell |
| 20-day EMA: | 52.58 | Sell |
| 50-day EMA: | 54.37 | Sell |
| 200-day EMA: | 50.54 | Sell |
Halozyme Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.04 | Sell |
| Relative Strength Index (14 RSI): | 35.09 | Sell |
| Chaikin Money Flow: | 1074433 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.74 - 58.56) | Sell |
| Bollinger Bands (100): | (51.51 - 60.57) | Sell |
Halozyme Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Halozyme Therapeutics Stock
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 45.76 while HALO 8-day simple moving average is 51.51, which is a Sell signal.
- The stock price of HALO is 45.76 while Halozyme Therapeutics 20-day SMA is 53.43, which makes it a Sell.
- Halozyme Therapeutics 50-day simple moving average is 55.29 while HALO share price is 45.76, making it a Sell technically.
- HALO stock price is 45.76 and Halozyme Therapeutics 200-day simple moving average is 49.09, creating a Sell signal.
HALO Technical Analysis vs Fundamental Analysis
Sell
44
Halozyme Therapeutics (HALO)
is a Sell
Is Halozyme Therapeutics a Buy or a Sell?
-
Halozyme Therapeutics stock is rated a Sell
The current Halozyme Therapeutics [HALO] share price is $45.76. The Score for HALO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Halozyme Therapeutics Stock Info
Market Cap:
5.82B
Price in USD:
45.76
Share Volume:
1.85M
Halozyme Therapeutics 52-Week Range
52-Week High:
65.53
52-Week Low:
33.15
Sell
44
Halozyme Therapeutics (HALO)
is a Sell
Halozyme Therapeutics Share Price Forecast
-
What is the Halozyme Therapeutics stock price today?
The Halozyme Therapeutics stock price is 45.76 USD today. -
Will HALO stock go up or go down?
Halozyme Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Halozyme Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Halozyme Therapeutics is overvalued.
Is Halozyme Therapeutics Stock a Buy?
- Halozyme Therapeutics share price is 45.76 while HALO 8-day exponential moving average is 49.51, which is a Sell signal.
- The stock price of HALO is 45.76 while Halozyme Therapeutics 20-day EMA is 52.58, which makes it a Sell.
- Halozyme Therapeutics 50-day exponential moving average is 54.37 while HALO share price is 45.76, making it a Sell technically.
- HALO stock price is 45.76 and Halozyme Therapeutics 200-day simple moving average is 50.54, creating a Sell signal.
Fundamental Analysis of Halozyme Therapeutics
Is Halozyme Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.
Technical Analysis of Halozyme Therapeutics
Should I short Halozyme Therapeutics stock?
- HALO Moving Average Covergence Divergence (MACD) indicator is -2.04, suggesting Halozyme Therapeutics is a Sell
- Halozyme Therapeutics Relative Strength Index (RSI) is 35.09, which suggest Halozyme Therapeutics is oversold
- The Bollinger Bands (25) for Halozyme Therapeutics is (47.74 - 58.56), which suggest Halozyme Therapeutics is a Sell
- The Bollinger Bands (100) for Halozyme Therapeutics is (51.51 - 60.57), which suggest Halozyme Therapeutics is a Sell
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.